In Brief: Millipore/Tylan
This article was originally published in The Gray Sheet
Executive Summary
Millipore/Tylan: Millipore inks definitive deal to acquire Tylan General for approximately $133 mil. in cash "plus the assumption of Tylan's outstanding debt," Millipore announces Dec. 16. San Diego-based Tylan General produces measurement and control products used to make non-medical microelectronics equipment. The company had 1996 sales of about $150 mil. The acquisition "significantly strengthens Millipore's competitive position in microelectronics, the company's fastest growing market over the past three years," Millipore says...
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.